THE WORLD’S ONLY POLY D,L LACTIde FOR APPLICATION AROUND THE EYE, FACE, NECK AND NECKLINE MESOTHERAPY.
Juvelook is a hybrid filler which have connected both benefits of immediate filling efect of HA (hyaluronic acid) and long-term stimulation of collagen production by PDLLA (Poly D,L – lactide).
Thanks to the patented manufacturing technology, patent no. 10-1481441, no. 10-1725279, a preparation with unique properties has been created: long-lasting effectiveness and an increased safety profile.
JUVELOOK is a time-active hybrid filler with a concentration of 42.5 mg of poly D,L lactide and 7.5 mg of non-cross-linked hyaluronic acid.
The effects of the therapy are visible immediately after injection. We obtain a filling effect thanks to the presence of hyaluronic acid. After about 2 weeks, the production of collagen is initiated by the presence of PDLLA lactic acid microparticles. The effects of the therapy last for over two years after the last treatment. The recommended number of treatments is 2 or 3, depending on the skin deficiency, at intervals of 6-8 weeks. After two years, we recommend performing 1 reminder treatment.
It is administered with a thin 27 g cannula near the lower eyelid or with thin needles, e.g. 31 G, by injecting into the lower part of the dermis to a depth of about 1.7 mm.
The product has been designed as a filler that works over time with a concentration of 42.5 mg PDLLA acid and 7.5 mg non-cross-linked hyaluronic acid. By adjusting the amount of the solution and the particle size from 10 to 40 micrometers and combining them with non-cross-linked hyaluronic acid, a hybrid was obtained that was adapted to the application of the mesotherapy method on the face, neck, neckline and eye area.
Add 5 ml of sterile water for injection to the vial. Place the preparation in a VORTEX laboratory shaker. After 30 minutes, the preparation is ready for use
In the case of injection of the preparation with a cannula, a specialist performs anesthesia of the injection site. In the case of large amounts of injections using the mesotherapy method, we recommend the use of a cream based on a 10.56% lidocaine crystal.
Performing the treatment with a needle or cannula.